Nektar Therapeutics Class Action Lawsuit
Company: Nektar Therapeutics
Ticker: (NASDAQ) NKTR
Class Action Period: February 26, 2025 - December 15, 2025
See If You Qualify For Monetary Reward
Join the Nektar Therapeutics Class Action Lawsuit
CLASS ACTION PERIOD
February 26, 2025 - December 15, 2025
Allegations
The complaint filed against Nektar Therapeutics alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (i) enrollment in the REZOLVE-AA trial had not followed applicable instructions and protocol standards; (ii) the foregoing was likely to have a significant negative impact on the REZOLVE-AA trial’s results; (iii) accordingly, the REZOLVE-AA trial’s overall integrity and prospects were overstated; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on Nektar Therapeutics shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Nektar Therapeutics during the relevant time frame, you have until May 5, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Nektar Therapeutics (NASDAQ: NKTR)?
Investors who purchased shares of Nektar Therapeutics (NASDAQ: NKTR) during the class period (February 26, 2025 - December 15, 2025) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is May 5, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Nektar Therapeutics lawsuit?
Anyone who bought shares of Nektar Therapeutics (NASDAQ: NKTR) during February 26, 2025 - December 15, 2025 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Nektar Therapeutics case?
The lead plaintiff deadline for the Nektar Therapeutics lawsuit is May 5, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Nektar Therapeutics?
The class period for Nektar Therapeutics (NASDAQ: NKTR) is February 26, 2025 - December 15, 2025, during which investors may have been affected by alleged misconduct.
- Can I still join the Nektar Therapeutics lawsuit if I sold my shares?
Yes. Investors who purchased Nektar Therapeutics shares during February 26, 2025 - December 15, 2025 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Nektar Therapeutics lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Nektar Therapeutics case may receive a portion of the recovery.
- Do I need to pay to participate in the Nektar Therapeutics case?
No, most securities fraud cases involving Nektar Therapeutics operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Nektar Therapeutics lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Nektar Therapeutics case on behalf of participants.
- What documents are required for the Nektar Therapeutics lawsuit?
To participate in the Nektar Therapeutics lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Nektar Therapeutics?
After submission, your details for the Nektar Therapeutics case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Nektar Therapeutics lawsuit?
No, this page provides information about the Nektar Therapeutics case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Nektar Therapeutics case?
The lead plaintiff deadline for the Nektar Therapeutics lawsuit is May 5, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Snowflake Inc.
SNOW
Lead Plaintiff Deadline: April 27, 2026
Class Period: June 27, 2023 - February 28, 2024
Navan, Inc.
NAVN
Lead Plaintiff Deadline: April 24, 2026
Class Period: October 31, 2025 - February 23, 2026